144 related articles for article (PubMed ID: 33816296)
1. LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis.
Wu K; Wang Q; Liu YL; Xiang Z; Wang QQ; Yin L; Liu SL
Front Oncol; 2021; 11():643613. PubMed ID: 33816296
[No Abstract] [Full Text] [Related]
2. Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy.
Ma S; Egyházi S; Martenhed G; Ringborg U; Hansson J
Melanoma Res; 2002 Aug; 12(4):335-42. PubMed ID: 12170182
[TBL] [Abstract][Full Text] [Related]
3. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
Busch C; Geisler J; Lillehaug JR; Lønning PE
Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
[TBL] [Abstract][Full Text] [Related]
4. Impact of Therapy Sequence with Alkylating Agents and MGMT Status in Patients with Advanced Neuroendocrine Tumors.
Krug S; Boch M; Rexin P; Gress TM; Michl P; Rinke A
Anticancer Res; 2017 May; 37(5):2491-2500. PubMed ID: 28476818
[TBL] [Abstract][Full Text] [Related]
5. LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3.
Liu Y; Zhuang Y; Fu X; Li C
Discov Oncol; 2021 Jul; 12(1):21. PubMed ID: 35201451
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy.
Ma S; Egyházi S; Ringborg U; Hansson J
Oncol Rep; 2002; 9(5):1015-9. PubMed ID: 12168066
[TBL] [Abstract][Full Text] [Related]
7. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment.
Li X; Yang C; Luo N; Yang Y; Guo Y; Chen P; Cun B
Cancer Biomark; 2022; 34(2):275-284. PubMed ID: 34958003
[TBL] [Abstract][Full Text] [Related]
9. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA
Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173
[TBL] [Abstract][Full Text] [Related]
10. O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C.
Passagne I; Evrard A; Depeille P; Cuq P; Cupissol D; Vian L
Toxicol Appl Pharmacol; 2006 Mar; 211(2):97-105. PubMed ID: 16039682
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-based strategies enhance antitumor capability through p53-mediated downregulation of MGMT in uveal melanoma.
Li X; Yuan L; Zhao J; Yang H; Yang Y; Zhang Y; Cun B
Cancer Biol Ther; 2017 Mar; 18(3):194-199. PubMed ID: 28278076
[TBL] [Abstract][Full Text] [Related]
12. A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo.
Chen TC; Cho HY; Wang W; Nguyen J; Jhaveri N; Rosenstein-Sisson R; Hofman FM; Schönthal AH
Cancer Lett; 2015 Mar; 358(2):144-151. PubMed ID: 25524552
[TBL] [Abstract][Full Text] [Related]
13. Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.
Sato K; Kitajima Y; Kohya N; Miyoshi A; Koga Y; Miyazaki K
Int J Oncol; 2005 Jun; 26(6):1653-61. PubMed ID: 15870882
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
[TBL] [Abstract][Full Text] [Related]
15. Analysis of O6-methylguanine-DNA methyltransferase mRNA in fine needle biopsies from human melanoma metastases by reverse transcription and polymerase chain reaction.
Hansson J; Martenhed G; Egyházi S; Tani E; Platz A
Eur J Cancer; 1996 Dec; 32A(13):2319-26. PubMed ID: 9038616
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents.
Wang G; Weiss C; Sheng P; Bresnick E
Biochem Pharmacol; 1996 May; 51(9):1221-8. PubMed ID: 8645346
[TBL] [Abstract][Full Text] [Related]
17. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis.
An LF; Huang JW; Han X; Wang J
Anticancer Drugs; 2020 Jun; 31(5):473-482. PubMed ID: 32265386
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-dependent expression of O(6)-methylguanine-DNA methyltransferase gene modulates dacarbazine-induced hepatotoxicity in mice.
Horiguchi M; Kim J; Matsunaga N; Kaji H; Egawa T; Makino K; Koyanagi S; Ohdo S
J Pharmacol Exp Ther; 2010 Jun; 333(3):782-7. PubMed ID: 20308330
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression.
Yeh YW; Hsu TW; Su YH; Wang CH; Liao PH; Chiu CF; Tseng PC; Chen TM; Lee WR; Tzeng YS
Aging (Albany NY); 2023 Nov; 15(22):12873-12889. PubMed ID: 37976135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]